These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11279953)

  • 1. Severe acne as a side effect of propranolol and nadolol in a migraineur.
    Bajwa ZH; Sami N; Flory C
    Headache; 1999; 39(10):758-60. PubMed ID: 11279953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of beta-blockers in migraine. A critical review.
    Tfelt-Hansen P
    Cephalalgia; 1986; 6 Suppl 5():15-24. PubMed ID: 2879629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the combination beta-blocker plus topiramate in refractory migraine.
    Pascual J; Rivas MT; Leira R
    Acta Neurol Scand; 2007 Feb; 115(2):81-3. PubMed ID: 17212609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta blockers in migraine prophylaxis].
    Shimizu T
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol versus nadolol for treatment of pediatric subglottic hemangioma.
    Yang W; Wolter NE; Cushing SL; Pope E; Wolter JK; Propst EJ
    Int J Pediatr Otorhinolaryngol; 2021 May; 144():110688. PubMed ID: 33773428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blockers and migraine].
    Massiou H; Bousser MG
    Pathol Biol (Paris); 1992 Apr; 40(4):373-80. PubMed ID: 1353872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
    Ryan RE
    Am Heart J; 1984 Oct; 108(4 Pt 2):1156-9. PubMed ID: 6148878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
    Krukemyer JJ; Boudoulas H; Binkley PF; Lima JJ
    Am Heart J; 1990 Sep; 120(3):572-9. PubMed ID: 2389694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine.
    Domingues RB; Silva AL; Domingues SA; Aquino CC; Kuster GW
    Arq Neuropsiquiatr; 2009 Dec; 67(4):973-7. PubMed ID: 20069203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death Associated With Nadolol for Infantile Hemangioma: A Case for Improving Safety.
    McGillis E; Baumann T; LeRoy J
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31852735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists.
    Saber AJ; Cain DP
    Neuropsychopharmacology; 2003 Jul; 28(7):1247-56. PubMed ID: 12700678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol.
    Mendizabal JE; Greiner F; Hamilton WJ; Rothrock JF
    Headache; 1997 Oct; 37(9):594-6. PubMed ID: 9385761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
    Priyam P; Sil A; Bhanja DB; Mondol DK
    Postgrad Med J; 2021 Apr; 97(1146):248-249. PubMed ID: 32303581
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of propranolol for migraine prophylaxis].
    Tfelt-Hansen P
    Ugeskr Laeger; 2005 Mar; 167(10):1181-3. PubMed ID: 15810579
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
    Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
    Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadolol instead of propranolol?
    Schiff AA
    Am J Psychiatry; 1983 Jul; 140(7):952-3. PubMed ID: 6134475
    [No Abstract]   [Full Text] [Related]  

  • 19. Nadolol and placebo comparison study in the prophylactic treatment of migraine.
    Freitag FG; Diamond S
    J Am Osteopath Assoc; 1984 Dec; 84(4):343-7. PubMed ID: 6150909
    [No Abstract]   [Full Text] [Related]  

  • 20. Nadolol and propranolol in migraine management.
    Olerud B; Gustavsson CL; Furberg B
    Headache; 1986 Nov; 26(10):490-3. PubMed ID: 3546194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.